Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot EMDA bladder instillation of Botox for overactive bladder in women
2015-001680-40Phase 4Completed
- Sponsor
- Sykehuset i Vestfold
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Sykehuset i Vestfold. Primary endpoints: Urinary Distress Inventory-6 (UDI-6) score, Incontinence Impact Questionnaire-7 (IIQ-7) score and 1 more. Started May 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2015-001680-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001680-40.